Original languageEnglish
Pages (from-to)FL01
JournalJournal of Clinical and Diagnostic Research
Volume10
Issue number3
DOIs
Publication statusPublished - 01-03-2016

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

@article{e69c4b94e0f5446d81eb875cf1d8130e,
title = "Are the newer antidiabetic agents worth the cost?",
author = "Sudhakar Pemminati and Millis, {Richard Mark} and Ashwin Kamath and Shenoy, {Ashok Kudgi} and Shivapraksh Gangachannaiah",
year = "2016",
month = "3",
day = "1",
doi = "10.7860/JCDR/2016/17683.7384",
language = "English",
volume = "10",
pages = "FL01",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "3",

}

Are the newer antidiabetic agents worth the cost? / Pemminati, Sudhakar; Millis, Richard Mark; Kamath, Ashwin; Shenoy, Ashok Kudgi; Gangachannaiah, Shivapraksh.

In: Journal of Clinical and Diagnostic Research, Vol. 10, No. 3, 01.03.2016, p. FL01.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Are the newer antidiabetic agents worth the cost?

AU - Pemminati, Sudhakar

AU - Millis, Richard Mark

AU - Kamath, Ashwin

AU - Shenoy, Ashok Kudgi

AU - Gangachannaiah, Shivapraksh

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84960121776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960121776&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2016/17683.7384

DO - 10.7860/JCDR/2016/17683.7384

M3 - Letter

AN - SCOPUS:84960121776

VL - 10

SP - FL01

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 3

ER -